Clinical Relevance of Etanercept Levels and Anti-Etanercept Antibodies in Long-Term Treatment of Rheumatoid Arthritis Patients

被引：0
|
作者：
Drynda, Susanne [1 ]
Kekow, Joern [1 ]
机构：
[1] Univ Magdeburg, Clin Rheumatol, Vogelsang Gommern, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
540
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ETANERCEPT SERUM TROUGH LEVELS ARE CORRELATED WITH CLINICAL ACTIVITY IN RHEUMATOID ARTHRITIS PATIENTS WITH LONG-TERM TREATMENT WITH ETANERCEPT
    Plasencia, C.
    Pascual-Salcedo, D.
    Alcozer, P.
    Garcia-Carazo, S.
    Franco, K. N.
    Cajigas, D.
    Bonilla, G.
    Lojo, L.
    Nuno, L.
    Villalba, A.
    Peiteado, D.
    Arribas, F.
    Lopez-Casla, M. T.
    Martin-Mola, E.
    Balsa, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 428 - 428
  • [2] DETERMINATION OF ANTI-DRUG ANTIBODIES IN LONG-TERM TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS WITH ETANERCEPT
    Drynda, S.
    Beuermann, R.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1033 - 1034
  • [3] ANTI-ETANERCEPT ANTIBODIES AND ETANERCEPT LEVES LEVELS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW AND FULL-DOSE ETANERCEPT IN DAS28 REMISSION
    Ometto, F.
    Beggio, M.
    Friso, L.
    Astorri, D.
    Raffeiner, B.
    Botsios, C.
    Bernardi, L.
    Padoan, R.
    Punzi, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 494 - 494
  • [4] Etanercept:: long-term clinical experience in rheumatoid arthritis and other arthritis
    Cobo-Ibanez, T.
    Martin-Mola, E.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1373 - 1397
  • [5] Long-Term Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis in Clinical Practice
    Lurati, Alfredomaria
    Bertani, Luca
    Re, Katia Angela
    Marrazza, Mariagrazia
    Bompane, Daniela
    Scarpellini, Magda
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 : S125 - S128
  • [6] Serum levels of cartilage oligomeric matrix protein during long-term treatment with etanercept in rheumatoid arthritis patients
    Riccieri, V
    Spadero, A
    Scrivo, R
    Germano, V
    Magrini, L
    Valesini, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 472 - 472
  • [7] Comparison of Long-Term Clinical Outcome With Etanercept Treatment and Adalimumab Treatment of Rheumatoid Arthritis With Respect to Immunogenicity
    Krieckaert, Charlotte L.
    Jamnitski, Anna
    Nurmohamed, Michael T.
    Kostense, Piet J.
    Boers, Maarten
    Wolbink, Gertjan
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 3850 - 3855
  • [8] Low and transient auto- and anti-etanercept antibody formation has no measurable impact on clinical outcomes during 5 years of etanercept (ENBREL) treatment in patients with rheumatoid arthritis
    Klareskog, L.
    Wajdula, J.
    Baker, P.
    Fatenejad, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 325 - 326
  • [9] Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate
    l'Ami, M. J.
    Kneepkens, E. L.
    Nurmohamed, M. T.
    Krieckaert, C. L. M.
    Visman, I. M.
    Wolbink, G. J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (03) : 431 - 437
  • [10] Radiographic outcome of treatment with etanercept in patients with rheumatoid arthritis in association to anti-CCP antibodies
    Drynda, S.
    Rossbach, A.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 147 - 147
12345